iPSCs at the forefront of technology
Our expert team is committed to continually improve and provide the most advanced solutions to our customers. Here you can find our latest innovations, news and events that reflect the value of iPSCs in drug discovery and how Ncardia is leveraging that value, as well as trends and developments in the field.
Case Study: A model of Alzheimer’s disease
Expert Insights: Large-scale manufacture of iPSC models
Research highlights: Drug repurposing for Parkinson's disease, using iPSCs
Interview: Leveraging iPSCs to accelerate drug discovery
Whitepaper: iPSC technology in Cardiac Drug Discovery
Expert Insights: 3D human iPSC-based cardiac models
Case Study: Manufacturing iPSC-derived skeletal muscle cells
Research highlights: Human iPSC-derived cardiomyocytes to study inherited cardiac ...
Expert Insights: iPSC-derived cardiomyocytes for cardiac drug discovery
Research highlights: Human iPSC technology can help reduce the gap between ...
Webinar: The potential of iPSC-derived endothelial cells for efficacy and safety ...
Webinar: Developing novel human iPSC models for atrial fibrillation
Webinar: Assessment of drug-induced structural toxicity in human iPSC-derived ...
Webinar Series: Modeling Neurodegenerative Diseases
Webinar: Human iPSCs-derived neuronal and glial cells as relevant models for ...
Webinar: Robust human iPSC-derived neuronal and glial in vitro drug discovery assays
Webinar: On the road to discovery
Webinar: Manufacture & co-culture of human iPSC-derived neuronal cell types
Webinar: Human iPSCs & High-Throughput Screening for Drug Discovery
Multi-parametric Safety Assessment in Bioreactor-produced Ncyte Cardiomyocytes
Press release: Ncardia launches Cellistic, an iPSC cell therapy CDMO
FDA Modernization Act of 2021: incorporating alternative testing platforms in drug ...
Press release: Ncardia Appoints Andy Holt as Chief Commercial Officer
Press release: Ncardia Secures $60+ Million to Enhance and Expand Leading iPSC ...
Press release: Cell & gene therapy accelerator to de-risk early stage research
Optimization of the Ncyte Astrocyte Kit
Press release: improving the early detection, prevention and treatment of lung ...
Ncardia and BlueRock Therapeutics Announce Collaboration Agreement and Licensing of ...
iCone Consortium hits milestone in large-scale production of iPSC-derived cortical ...
INSPIRE: A European safety pharmacology training network
Subscribe to our newsletter
Stay up to date on iPSC innovations, events and news.